Form 4: Crinetics Pharmaceuticals COO Jeff E. Knight Reports Stock Transactions
SEC Form 4
Jeff E. Knight, Chief Operating Officer of Crinetics Pharmaceuticals, reports the exercise of stock options and sale of common stock on July 15, 2024, according to a Form 4 filing.
Summary
- On July 15, 2024, Jeff E. Knight, the Chief Operating Officer of Crinetics Pharmaceuticals, executed multiple transactions involving the company's stock.
- Knight exercised stock options to acquire 17,499 shares at $23.98, 2,887 shares at $20.02, and 5,687 shares at $19.64.
- Simultaneously, Knight sold 27,000 shares of common stock at $55.
- Following these transactions, Knight directly owns 51,653 shares of Crinetics Pharmaceuticals.
- The sale was executed automatically pursuant to a Rule 10b5-1 trading plan.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it is a standard disclosure of stock transactions by an officer. The transactions themselves don't necessarily indicate a positive or negative outlook.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor management's perspective on the company's stock.
Stakeholder Impact
- The transactions may influence investor perception of the company's stock, but the impact is likely to be minimal given the pre-planned nature of the sale.
Key Dates
| Date | Description |
|---|---|
| 08/30/2022 | 25% of shares subject to one stock option vest |
| 03/31/2022 | 1/48th of the shares subject to one stock option vested |
| 04/01/2023 | 1/48th of the shares subject to one stock option vested |
| 07/15/2024 | Date of stock option exercises and stock sale |
| 07/17/2024 | Date of Form 4 signature |
| 09/01/2031 | Expiration date of one stock option |
| 02/29/2032 | Expiration date of one stock option |
| 03/01/2033 | Expiration date of one stock option |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.